A Newer Class of Migraine Drugs Is Linked to a 40% Rise in Miscarriage Risk

"Further research is needed to evaluate their safety during pregnancy." ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.